AIMS AMP Capital Industrial REIT: Target price?

Closing at 23.5c on higher volume shows a continuing and heightened interest in this REIT.  This is especially true when we remember that this is after the counter has gone XR!  Buying at 23.5c and with an expected DPU of 2.08c, the yield works out to be 8.85% per annum.  Apparently, many feel that this yield is still attractive for them.  If we think of it objectively, it is still rather high, relative to some "blue chip" REITs, for example.

MFI continues to climb higher but is not yet overbought.  OBV too continues its climb upwards.  Demand remains strong and accumulation is relentless.  RSI rose higher into overbought territory suggesting that the buying momentum is somewhat overdone but the MACD continues pulling away upwards from the signal line in positive territory.  Momentum is currently positive and in very bullish situations, the RSI could stay overbought for a while longer.

This is a long shot but if 23.5c should be taken out convincingly, we could even see 25c tested.  At 25c, a DPU of 2.08c would translate into a yield of 8.32% per annum.  Still attractive for some? Perhaps.

Related post:
AIMS AMP Capital Industrial REIT: XR.

Healthway Medical: 20c target.

Standard Chartered has suggested a target price of 20c for Healthway Medical. They arrived at this target price after highlighting a slew of difficulties the company faces:

1. Opening chain of clinics in China and setting up specialist center in Singapore are facing challenges in execution.

2. The group has not delivered good execution in its specialist services in the past and has limited experience of organic expansion.

3. Mass exodus of prominent specialist doctors from Healthway’s employment is also troublesome. 

4. Cost pressure mounting due to aggressive expansion.

I am almost 100% divested and I am still waiting for its share price to fall to a more reasonable level before I load up once more because if the management does deliver on its expansion plans, the company's share price would fly. At the current price, valuation is simply astronomical.

Standard Chartered's target price of 20c implies a PE of 36x!  This is almost as ridiculous as Q&M Dental Group's valuation when they first listed!  Please bear in mind that my considerations here are based on FA.  There is no accounting for sentiments.

Related post:
Healthway Medical: Second quarter results.